Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

The potential for cardiac implantable electronic device leads to interfere with tricuspid valve
(TV) function has gained increasing recognition as having hemodynamic and clinical …

Approximately 4% of subjects aged 75 years or more have clinically relevant tricuspid
regurgitation (TR). Primary TR results from anatomical abnormality of the tricuspid valve …

The assessment and management of tricuspid valve disease have evolved substantially
during the past several years. Whereas tricuspid stenosis is uncommon, tricuspid …

731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Cardiovascular specialists have entered an era of renewed interest and enthusiasm
surrounding the diagnosis and treatment of valvular heart disease, driven in part by …

Tricuspid valve (TV) disease has been relatively neglected, despite the known association
between severe tricuspid regurgitation (TR) and mortality. Few patients undergo isolated …

With the expanding use of cardiac implantable electronic device (CIEDs) in an ever-aging
population, the looming problem of CIED-associated interference with the tricuspid valve is …

Background Although the presence of an RV lead is a potential cause of tricuspid
regurgitation (TR), the clinical impact of significant lead-induced TR is unknown. Objective …

Estimates of the prevalence and importance of significant tricuspid regurgitation (STR)
related to implantable device leads are based mainly on case reports, small observational …